Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial.
Jama Oncology
Yap, Timothy A TA; Bardia, Aditya A; Dvorkin, Michael M; Galsky, Matthew D MD; Beck, J Thaddeus JT; Wise, David R DR; Karyakin, Oleg O; Rubovszky, Gábor G; Kislov, Nikolay N; Rohrberg, Kristoffer K; Joy, Anil Abraham AA; Telli, Melinda L ML; Schram, Alison M AM; Conte, Umberto U; Chappey, Colombe C; Stewart, Ross R; Stypinski, Daria D; Michelon, Elisabete E; Cesari, Rossano R; Konstantinopoulos, Panagiotis A PA
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.
Nature Medicine
Gogishvili, Miranda M; Melkadze, Tamar T; Makharadze, Tamta T; Giorgadze, Davit D; Dvorkin, Mikhail M; Penkov, Konstantin K; Laktionov, Konstantin K; Nemsadze, Gia G; Nechaeva, Marina M; Rozhkova, Irina I; Kalinka, Ewa E; Gessner, Christian C; Moreno-Jaime, Brizio B; Passalacqua, Rodolfo R; Li, Siyu S; McGuire, Kristina K; Kaul, Manika M; Paccaly, Anne A; Quek, Ruben G W RGW; Gao, Bo B; Seebach, Frank F; Weinreich, David M DM; Yancopoulos, George D GD; Lowy, Israel I; Gullo, Giuseppe G; Rietschel, Petra P
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Verset, Gontran G; Borbath, Ivan I; Karwal, Mark M; Verslype, Chris C; Van Vlierberghe, Hans H; Kardosh, Adel A; Zagonel, Vittorina V; Stal, Per P; Sarker, Debashis D; Palmer, Daniel H DH; Vogel, Arndt A; Edeline, Julien J; Cattan, Stephane S; Kudo, Masatoshi M; Cheng, Ann-Lii AL; Ogasawara, Sadahisa S; Daniele, Bruno B; Chan, Stephen L SL; Knox, Jennifer J JJ; Qin, Shukui S; Siegel, Abby B AB; Chisamore, Michael M; Hatogai, Ken K; Wang, Anran A; Finn, Richard S RS; Zhu, Andrew X AX
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
Journal For Immunotherapy Of Cancer
D'Angelo, Sandra P SP; Lebbé, Celeste C; Mortier, Laurent L; Brohl, Andrew S AS; Fazio, Nicola N; Grob, Jean-Jacques JJ; Prinzi, Natalie N; Hanna, Glenn J GJ; Hassel, Jessica C JC; Kiecker, Felix F; Georges, Sara S; Ellers-Lenz, Barbara B; Shah, Parantu P; Güzel, Gülseren G; Nghiem, Paul P